Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,866 | -6,392 | -24,669 | -18,489 | -12,392 |
| Depreciation Amortization | 274 | 136 | 525 | 395 | 262 |
| Accounts payable and accrued liabilities | 656 | -369 | 88 | -293 | 474 |
| Other Working Capital | 382 | -368 | -420 | -559 | 168 |
| Other Operating Activity | 1,882 | 1,884 | 8,857 | 7,183 | 4,208 |
| Operating Cash Flow | $-9,672 | $-5,109 | $-15,619 | $-11,763 | $-7,280 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -26 | -5 | -115 | -106 | -92 |
| Purchase Of Investment | -15,099 | -8,628 | -48,127 | -42,214 | -38,286 |
| Sale Of Investment | 24,956 | 11,460 | 13,688 | 2,250 | N/A |
| Investing Cash Flow | $9,831 | $2,827 | $-34,554 | $-40,070 | $-38,378 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 4,555 | 4,555 | 54,728 | 54,728 | 54,728 |
| End Cash Position | 4,714 | 2,273 | 4,555 | 2,895 | 9,070 |
| Net Cash Flow | $159 | $-2,282 | $-50,173 | $-51,833 | $-45,658 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,672 | -5,109 | -15,619 | -11,763 | -7,280 |
| Capital Expenditure | -26 | -5 | -115 | -106 | -92 |
| Free Cash Flow | -9,698 | -5,114 | -15,734 | -11,869 | -7,372 |